| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | Chief Regulatory Officer | Common Stock | 92,303 | $194,740 | $2.11 | 16 Jan 2026 | Direct |
| Acumen Pharmaceuticals, Inc. | Chief Regulatory Officer | Employee Stock Option (right to buy) | 126,900 | 16 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | 16 Jan 2026 | 2 | $0 | 4 | Chief Regulatory Officer | 21 Jan 2026, 18:29 |
| ABOS | Acumen Pharmaceuticals, Inc. | 07 Jan 2026 | 1 | -$2,176 | 4 | Chief Regulatory Officer | 09 Jan 2026, 16:38 |
| ABOS | Acumen Pharmaceuticals, Inc. | 06 Jan 2025 | 2 | $0 | 4 | Chief Regulatory Officer | 07 Jan 2025, 20:02 |
| ABOS | Acumen Pharmaceuticals, Inc. | 05 Nov 2024 | 1 | $0 | 4 | Chief Regulatory Officer | 06 Nov 2024, 17:27 |
| ABOS | Acumen Pharmaceuticals, Inc. | 05 Nov 2024 | 0 | $0 | 3 | Chief Regulatory Officer | 06 Nov 2024, 17:24 |